The Bournemouth Research Hub at Royal Bournemouth Hospital is recruiting participants for a UK trial of an investigational mRNA vaccine aimed at preventing influenza pandemics, notably avian flu. The phase 3 study will gauge the safety and immune response to the mRNA-1018 vaccine, with around 4,000 adults expected to participate. Supported by multiple organizations, including Moderna and the UK Health Security Agency, the trial hopes to enhance pandemic preparedness against H5N1 strains. Dr. Patrick Moore emphasizes that bird flu is a pressing issue with potential pandemic risk, encouraging local involvement in this vital research.
See more from the Daily Echo here.
Posted inExternal